This conference stands as a landmark event for the Botton-Champalimaud Pancreatic Cancer Centre in 2025 and will unite leading minds in translational science, oncology and surgery to tackle the complexities of pancreatic cancer.

The conference will serve as a pivotal platform for the exchange of groundbreaking insights, state-of-the-art surgical methodologies, and innovative therapeutic approaches that will ultimately enhance patient care and outcomes on a global scale.

More than 400 participants are expected in Lisbon for the 3-day multi-track event that will bring together 95 world-renowned cancer specialists for what will be an extremely stimulating scientific conference.
‍